Dino Di Carlo
Gründer bei Cytovale, Inc.
Profil
Dino Di Carlo has founded Forcyte Biotechnologies, Inc. in 2017 and Cytovale, Inc. in 2013, where he currently holds the title of Director.
Dr. Di Carlo is also the founder of Tempo Therapeutics, Inc., Partillion Bioscience Corp...
Aktive Positionen von Dino Di Carlo
| Unternehmen | Position | Beginn |
|---|---|---|
Cytovale, Inc.
 Cytovale, Inc. Miscellaneous Commercial ServicesCommercial Services Cytovale, Inc. develops mechanical biomarkers to improve human health based on the mechanical properties of individual cells or mechanomics. The company was founded by Dino Di Carlo, Ajay M. Shah and Tat Kwong Tse in 2013 and is headquartered in San Francisco, CA. | Gründer | 01.01.2013 |
Tempo Therapeutics, Inc.
 Tempo Therapeutics, Inc. BiotechnologyHealth Technology Tempo Therapeutics, Inc. engages in development of materials that are immune stealth, minimally invasive, and precision engineered for regenerative medicine. Its pipeline TT101, TT102, TT201. and TT301. The company was founded by Westbrook Weaver, Philip Scumpia, Dino Di Carlo, Tatiana Segura, and Donald Griffin and is headquartered in San Diego, CA. | Gründer | - |
Partillion Bioscience Corp.
 Partillion Bioscience Corp. Miscellaneous Commercial ServicesCommercial Services Partillion Bioscience Corp. is an American company that specializes in providing a functional single-cell biology reagent platform. The company's nanovial technology allows for single-cell secretion analysis and other research capabilities. The company was founded by Joseph Michael de Rutte and Dino Di Carlo, with Joseph Michael de Rutte serving as CEO since incorporation. | Gründer | - |
Ehemalige bekannte Positionen von Dino Di Carlo
| Unternehmen | Position | Ende |
|---|---|---|
Forcyte Biotechnologies, Inc.
 Forcyte Biotechnologies, Inc. Packaged SoftwareTechnology Services Forcyte Biotechnologies, Inc. provides biotechnological services. The firm builds the platform for the discovery of small molecule drugs that control mechanical force generation in individual human cells. The company was founded by Ivan Pushkarsky, Dino Di Carlo and Robert Damoiseaux in 2017 and is headquartered in Los Angeles, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Cytovale, Inc.
Cytovale, Inc. Miscellaneous Commercial ServicesCommercial Services Cytovale, Inc. develops mechanical biomarkers to improve human health based on the mechanical properties of individual cells or mechanomics. The company was founded by Dino Di Carlo, Ajay M. Shah and Tat Kwong Tse in 2013 and is headquartered in San Francisco, CA. | Commercial Services |
Tempo Therapeutics, Inc.
Tempo Therapeutics, Inc. BiotechnologyHealth Technology Tempo Therapeutics, Inc. engages in development of materials that are immune stealth, minimally invasive, and precision engineered for regenerative medicine. Its pipeline TT101, TT102, TT201. and TT301. The company was founded by Westbrook Weaver, Philip Scumpia, Dino Di Carlo, Tatiana Segura, and Donald Griffin and is headquartered in San Diego, CA. | Health Technology |
Forcyte Biotechnologies, Inc.
Forcyte Biotechnologies, Inc. Packaged SoftwareTechnology Services Forcyte Biotechnologies, Inc. provides biotechnological services. The firm builds the platform for the discovery of small molecule drugs that control mechanical force generation in individual human cells. The company was founded by Ivan Pushkarsky, Dino Di Carlo and Robert Damoiseaux in 2017 and is headquartered in Los Angeles, CA. | Technology Services |
Partillion Bioscience Corp.
Partillion Bioscience Corp. Miscellaneous Commercial ServicesCommercial Services Partillion Bioscience Corp. is an American company that specializes in providing a functional single-cell biology reagent platform. The company's nanovial technology allows for single-cell secretion analysis and other research capabilities. The company was founded by Joseph Michael de Rutte and Dino Di Carlo, with Joseph Michael de Rutte serving as CEO since incorporation. | Commercial Services |
